May 20, 2025
37:25
For every 25 shares held, investors received 37. The price per share adjusted from $30.01 to $20.28.
The split itself did not change the total investment value.
Zhejiang Haisen Pharmaceutical Co., Ltd. Class A (SZSE:001367) operates in the Chemicals: specialty industry.
Zhejiang Haisen Pharmaceutical Co., Ltd. Class A company overviewZhejiang Haisen Pharmaceutical Co., Ltd. Class A's most recent stock split was on May 20, 2025. It was a 37-for-25 forward split, so shareholders received 37 shares for every 25 they held.
Zhejiang Haisen Pharmaceutical Co., Ltd. Class A (SZSE:001367) has split its stock 2 times: a 37-for-25 split on June 18, 2024 and a 37-for-25 split on May 20, 2025.
Zhejiang Haisen Pharmaceutical Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between June 18, 2024 and May 20, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Haisen Pharmaceutical Co., Ltd. Class A's 37-for-25 split on May 20, 2025, every 25 shares became 37 shares.
Zhejiang Haisen Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 20, 2025, 1 year ago. Companies announce splits in advance, and any new SZSE:001367 split will appear on this page.
Already premium?